Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 151 to 160 of 1090 total matches.
Pregabalin (Lyrica) for Fibromyalgia
The Medical Letter on Drugs and Therapeutics • Sep 24, 2007 (Issue 1270)
, Pharm.D.
CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten,
Pharm.D., University of Washington ...
Pregabalin (Lyrica - Pfizer) is the first drug approved by the FDA for management of fibromyalgia. When it was first marketed, pregabalin, which is structurally similar to gabapentin (Neurontin, and others), was approved for treatment of neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy and for adjunctive treatment of partial onset seizures in adults with epilepsy. It has also been prescribed off-label for other types of neuropathic pain such as sciatica.
Terbinafine for Onychomycosis
The Medical Letter on Drugs and Therapeutics • Aug 16, 1996 (Issue 981)
have been published, and hepatic toxicity and drug interactions can
be troublesome with ketoconazole.
Itraconazole ...
Terbinafine (Lamisil - Sandoz), an allylamine synthetic antifungal, previously available in the USA in a topical formulation (Medical Letter, 35:76, 1993) has now been marketed for oral use in the treatment of fungal nail infections caused by dermatophytes. Oral terbinafine has been available in Europe since 1992.
Dirithromycin
The Medical Letter on Drugs and Therapeutics • Nov 24, 1995 (Issue 962)
drug interactions have not been reported. Other macrolides interact with various drugs, including ...
Dirithromycin (Dynabac - manufactured by Lilly, distributed by Bock), an oral macrolide antibiotic chemically similar to erythromycin, clarithromycin (Biaxin) and azithromycin (Zithromax), has been approved for marketing by the US Food and Drug Administration (FDA).
Rifabutin
The Medical Letter on Drugs and Therapeutics • Apr 30, 1993 (Issue 895)
INTERACTIONS — Rifabutin can induce hepatic microsomal enzymes that metabolize
other drugs and decrease ...
Rifabutin (formerly ansamycin; Mycobutin - Adria), a rifamycin antibiotic similar to rifampin (Rifadin, Rimactane) was recently approved by the US Food and Drug Administration for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
Alosetron (Lotronex) For Treatment of Irritable Bowel Syndrome
The Medical Letter on Drugs and Therapeutics • Jun 26, 2000 (Issue 1081)
COPYRIGHT LAWS 53
INTERACTIONS — No adverse drug interactions have been reported with alosetron. The
drug ...
Alosetron hydrochloride (Lotronex - Glaxo Welcome), a selective serotonin receptor antagonist, has received FDA approval for treatment of irritable bowel syndrome (IBS) in women whose primary bowel symptom is diarrhea.
Pioglitazone/Glimepiride (Duetact) for Diabetes
The Medical Letter on Drugs and Therapeutics • Jan 29, 2007 (Issue 1253)
.
DRUG INTERACTIONS — Specific pharmacokinetic
drug interaction studies have not been conducted ...
Duetact (Takeda), a new fixed-dose combination of the thiazolidinedione pioglitazone (Actos) and the sulfonylurea glimepiride (Amaryl, and others), was recently approved by the FDA for treatment of type 2 diabetes. It is approved as an adjunct to diet and exercise to improve glycemic control in patients already taking pioglitazone and/or a sulfonylurea. Avandaryl, a combination of glimepiride and the thiazolidinedione rosiglitazone, was approved in 2006.
Ambrisentan (Letairis) for Pulmonary Arterial Hypertension
The Medical Letter on Drugs and Therapeutics • Oct 22, 2007 (Issue 1272)
be obtained monthly.
DRUG INTERACTIONS — No significant interactions
have been observed between ambrisentan ...
Ambrisentan (Letairis - Gilead), a selective endothelin type A (ETA) receptor antagonist, has been approved by the FDA for treatment of symptomatic patients (WHO class II or III) with pulmonary arterial hypertension (PAH).
In Brief: Fexofenadine (Allegra) and Fruit Juice
The Medical Letter on Drugs and Therapeutics • May 30, 2011 (Issue 1365)
type of food-drug interaction. Br J Clin Pharmacol 2010;
70:645. Allegra antihistamines cetirizine ...
Fexofenadine (Allegra, and others) is the most recent second-generation H1-antihistamine to become available over the counter (OTC). Cetirizine (Zyrtec, and others) and loratadine (Claritin, and others) are already available OTC. Cetirizine can be sedating in usual doses. Loratadine can be sedating in higher-than-usual doses. Fexofenadine remains nonsedating even in higher doses.
Nilotinib (Tasigna) for CML
The Medical Letter on Drugs and Therapeutics • Apr 07, 2008 (Issue 1283)
and elevations in serum
lipase, bilirubin and transaminases have been
reported.
DRUG INTERACTIONS — Nilotinib ...
Nilotinib (Tasigna - Novartis), a tyrosine kinase inhibitor, has been approved by the FDA for treatment of Philadelphia chromosome-positive (Ph+) chronic or accelerated phase chronic myelogenous leukemia (CML) in patients resistant to or intolerant of imatinib (Gleevec).
Lapatinib (Tykerb) for Advanced Breast Cancer
The Medical Letter on Drugs and Therapeutics • Sep 10, 2007 (Issue 1269)
have
been associated with lapatinib use in both monotherapy and combination treatment.
DRUG INTERACTIONS — Lapatinib ...
Lapatinib (Tykerb - GlaxoSmithKline), an oral inhibitor of both HER-2 and epidermal growth factor receptor type 1 (EGFR-1 or ErbB-1), has been approved by the FDA for use in combination with capecitabine (Xeloda) to treat advanced or metastatic breast cancer that overexpresses HER-2 in patients who have received prior therapy that included an anthracycline, a taxane and trastuzumab (Herceptin), an intravenous monoclonal antibody that also inhibits HER-2.